← Leaderboards
Andreas Walz
Ophidion, Inc.
$828,017
Attributed
$828,017
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $328K · FY2008–11$500K$375K$250K$125K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$828,017 · 2
By mechanism
R43$828,017 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Parkinson Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson DiseaseSchizophreniaMemoryNicotinic ReceptorsPhysiologicalReceptor FunctionLeadLearningNervous System DisorderNeuronsGenesAlzheimer&AposReceptor CellBiologicalCognitive FunctionIn VivoAttentionCognitionCell LineCellsCholinergicComplexBaseS Disease
Grant awards (3)
Biologic approach to targeting a nicotinic receptor accessory molecule for cognit$328,017
R43 · FY2011 · MH · contact PI
Improved Cell Line and Assay Development of Nicotinic Receptor Complexes for HTS$250,000
R43 · FY2009 · MH · contact PI
Improved Cell Line and Assay Development of Nicotinic Receptor Complexes for HTS$250,000
R43 · FY2008 · MH · contact PI